For example, DNAm of the peroxisome proliferator-activated receptor γ (PPARγ) gene promoter has been found to associate with severe versus mild fibrosis in NAFLD [11]. This evidence concerns the gene PPARG and metabolic dysfunction-associated steatotic liver disease.